Skip to content
investormap

BiomedVC

Venture capital

UncertainLast verified 6 Nov 2026

BiomedVC is a Swiss early-stage venture capital firm investing in European biotechnology startups developing innovative therapeutics, focusing primarily on Seed and Series A rounds across the DACH region.

0 deals in the last 24 months. Taken from its own website.

Key facts

Stages
Seed, Series A
Sectors
Biotech & pharma
Eligible countries
Not stated
Provider based in
Switzerland
Timing
Rolling applications
Focus
biotech; innovative therapeutics; life sciences
How to apply
Apply route unknown

Recent deals

No deals in our data for the last 24 months.

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

  • KindBiomed is a leading Swiss early-stage VC at the center of European biotech.https://biomedvc.com/
  • Sectorsempowering the next generation of Life Science entrepreneurs to take their scientific innovation from academic labs and build them into venture-backed…https://biomedvc.com/
  • StagesWe support first-time teams or experienced founders with initial investments in Seed and Series A stageshttps://biomedvc.com/

Status history

  • 6 Nov 2026: Rolling → Uncertain (freshness: investor activity)
  • 6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at BiomedVC? Claim this profile to confirm what you invest in.